Immix Biopharma, Inc. (IMMX) Net Income by Year
Immix Biopharma, Inc. reported a net loss of $29.4M in fiscal year 2025. This represents a decrease of 36.0% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Immix Biopharma, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
IMMX Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
IMMX Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Immix Biopharma, Inc. financials
Frequently Asked Questions
What was Immix Biopharma, Inc.'s net income in fiscal year 2025?
Immix Biopharma, Inc. reported a net loss of $29.4M in fiscal year 2025.
How fast is Immix Biopharma, Inc.'s net income growing?
Immix Biopharma, Inc. (IMMX) net income fell by 36.0% year over year, from -$21.6M to -$29.4M in fiscal year 2025.
How has Immix Biopharma, Inc.'s net income changed over the years?
Across the 6 fiscal years this page covers, Immix Biopharma, Inc. (IMMX) net income went from -$1.1M in fiscal year 2020 to -$29.4M in fiscal year 2025.
What was Immix Biopharma, Inc.'s net income in the most recent quarter?
Immix Biopharma, Inc. (IMMX) reported -$11.6M in net income in Q2 2026. This represents a decrease of 74.5% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Immix Biopharma, Inc. (IMMX) reported on that line in every period on record.